The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Conjugate Vaccine Market Research Report 2025
Synopsis
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
The global Conjugate Vaccine market was valued at US$ 9995.1 million in 2023 and is anticipated to reach US$ 12490 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugate Vaccine.
Report Scope
The Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Segment by Type
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segment by End Users
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
The global Conjugate Vaccine market was valued at US$ 9995.1 million in 2023 and is anticipated to reach US$ 12490 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
Market competition is intense. Pfizer, GSK, Sanofi, Merck, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 86.11% market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Conjugate Vaccine.
Report Scope
The Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Million Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by End Users, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by End Users, and by regions.
Market Segmentation
By Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Bharat Biotech
Zhifei Biologic
Segment by Type
Hib Vaccine
Meningococcal Vaccine
Pneumococcal Vaccine
Others
Segment by End Users
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by End Users, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Conjugate Vaccine Market Overview
1.1 Product Overview and Scope of Conjugate Vaccine
1.2 Conjugate Vaccine Segment by Type
1.2.1 Global Conjugate Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Conjugate Vaccine Segment by End Users
1.3.1 Global Conjugate Vaccine Market Value by End Users: (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Conjugate Vaccine Revenue 2019-2030
1.4.2 Global Conjugate Vaccine Sales 2019-2030
1.4.3 Global Conjugate Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Conjugate Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Conjugate Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Conjugate Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
2.7 Conjugate Vaccine Market Competitive Situation and Trends
2.7.1 Conjugate Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Conjugate Vaccine Players Market Share by Revenue
2.7.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Conjugate Vaccine Retrospective Market Scenario by Region
3.1 Global Conjugate Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Conjugate Vaccine Global Conjugate Vaccine Sales by Region: 2019-2030
3.2.1 Global Conjugate Vaccine Sales by Region: 2019-2024
3.2.2 Global Conjugate Vaccine Sales by Region: 2025-2030
3.3 Global Conjugate Vaccine Global Conjugate Vaccine Revenue by Region: 2019-2030
3.3.1 Global Conjugate Vaccine Revenue by Region: 2019-2024
3.3.2 Global Conjugate Vaccine Revenue by Region: 2025-2030
3.4 North America Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Conjugate Vaccine Sales by Country (2019-2030)
3.4.3 North America Conjugate Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Conjugate Vaccine Sales by Country (2019-2030)
3.5.3 Europe Conjugate Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Conjugate Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Conjugate Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Conjugate Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Conjugate Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Conjugate Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Conjugate Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Conjugate Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Conjugate Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Conjugate Vaccine Sales by Type (2019-2030)
4.1.1 Global Conjugate Vaccine Sales by Type (2019-2024)
4.1.2 Global Conjugate Vaccine Sales by Type (2025-2030)
4.1.3 Global Conjugate Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Conjugate Vaccine Revenue by Type (2019-2030)
4.2.1 Global Conjugate Vaccine Revenue by Type (2019-2024)
4.2.2 Global Conjugate Vaccine Revenue by Type (2025-2030)
4.2.3 Global Conjugate Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Conjugate Vaccine Price by Type (2019-2030)
5 Segment by End Users
5.1 Global Conjugate Vaccine Sales by End Users (2019-2030)
5.1.1 Global Conjugate Vaccine Sales by End Users (2019-2024)
5.1.2 Global Conjugate Vaccine Sales by End Users (2025-2030)
5.1.3 Global Conjugate Vaccine Sales Market Share by End Users (2019-2030)
5.2 Global Conjugate Vaccine Revenue by End Users (2019-2030)
5.2.1 Global Conjugate Vaccine Revenue by End Users (2019-2024)
5.2.2 Global Conjugate Vaccine Revenue by End Users (2025-2030)
5.2.3 Global Conjugate Vaccine Revenue Market Share by End Users (2019-2030)
5.3 Global Conjugate Vaccine Price by End Users (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Conjugate Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Conjugate Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Conjugate Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Walvax Biotechnology Conjugate Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Royal (Wuxi) Bio-Pharmaceutical
6.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
6.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
6.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio
6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.7 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bharat Biotech Conjugate Vaccine Product Portfolio
6.7.5 Bharat Biotech Recent Developments/Updates
6.8 Zhifei Biologic
6.8.1 Zhifei Biologic Corporation Information
6.8.2 Zhifei Biologic Description and Business Overview
6.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhifei Biologic Conjugate Vaccine Product Portfolio
6.8.5 Zhifei Biologic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Conjugate Vaccine Industry Chain Analysis
7.2 Conjugate Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Conjugate Vaccine Production Mode & Process
7.4 Conjugate Vaccine Sales and Marketing
7.4.1 Conjugate Vaccine Sales Channels
7.4.2 Conjugate Vaccine Distributors
7.5 Conjugate Vaccine Customers
8 Conjugate Vaccine Market Dynamics
8.1 Conjugate Vaccine Industry Trends
8.2 Conjugate Vaccine Market Drivers
8.3 Conjugate Vaccine Market Challenges
8.4 Conjugate Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Conjugate Vaccine Market Value Comparison by End Users (2024-2030) & (US$ Million)
Table 3. Global Conjugate Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Conjugate Vaccine Sales (Million Unit) of Key Manufacturers (2019-2024)
Table 5. Global Conjugate Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Conjugate Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Conjugate Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Conjugate Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Conjugate Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Conjugate Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Conjugate Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Conjugate Vaccine Sales by Region (2019-2024) & (Million Unit)
Table 18. Global Conjugate Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Conjugate Vaccine Sales by Region (2025-2030) & (Million Unit)
Table 20. Global Conjugate Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Conjugate Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Conjugate Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Conjugate Vaccine Sales by Country (2019-2024) & (Million Unit)
Table 27. North America Conjugate Vaccine Sales by Country (2025-2030) & (Million Unit)
Table 28. North America Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Conjugate Vaccine Sales by Country (2019-2024) & (Million Unit)
Table 32. Europe Conjugate Vaccine Sales by Country (2025-2030) & (Million Unit)
Table 33. Europe Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Conjugate Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Conjugate Vaccine Sales by Region (2019-2024) & (Million Unit)
Table 37. Asia Pacific Conjugate Vaccine Sales by Region (2025-2030) & (Million Unit)
Table 38. Asia Pacific Conjugate Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Conjugate Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Conjugate Vaccine Sales by Country (2019-2024) & (Million Unit)
Table 42. Latin America Conjugate Vaccine Sales by Country (2025-2030) & (Million Unit)
Table 43. Latin America Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Conjugate Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Conjugate Vaccine Sales by Country (2019-2024) & (Million Unit)
Table 47. Middle East & Africa Conjugate Vaccine Sales by Country (2025-2030) & (Million Unit)
Table 48. Middle East & Africa Conjugate Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Conjugate Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Conjugate Vaccine Sales (Million Unit) by Type (2019-2024)
Table 51. Global Conjugate Vaccine Sales (Million Unit) by Type (2025-2030)
Table 52. Global Conjugate Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Conjugate Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Conjugate Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Conjugate Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Conjugate Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Conjugate Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Conjugate Vaccine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Conjugate Vaccine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Conjugate Vaccine Sales (Million Unit) by End Users (2019-2024)
Table 61. Global Conjugate Vaccine Sales (Million Unit) by End Users (2025-2030)
Table 62. Global Conjugate Vaccine Sales Market Share by End Users (2019-2024)
Table 63. Global Conjugate Vaccine Sales Market Share by End Users (2025-2030)
Table 64. Global Conjugate Vaccine Revenue (US$ Million) by End Users (2019-2024)
Table 65. Global Conjugate Vaccine Revenue (US$ Million) by End Users (2025-2030)
Table 66. Global Conjugate Vaccine Revenue Market Share by End Users (2019-2024)
Table 67. Global Conjugate Vaccine Revenue Market Share by End Users (2025-2030)
Table 68. Global Conjugate Vaccine Price (USD/Unit) by End Users (2019-2024)
Table 69. Global Conjugate Vaccine Price (USD/Unit) by End Users (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Conjugate Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK Conjugate Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi Conjugate Vaccine Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Merck Conjugate Vaccine Product
Table 89. Merck Recent Developments/Updates
Table 90. Walvax Biotechnology Corporation Information
Table 91. Walvax Biotechnology Description and Business Overview
Table 92. Walvax Biotechnology Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Walvax Biotechnology Conjugate Vaccine Product
Table 94. Walvax Biotechnology Recent Developments/Updates
Table 95. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 96. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 97. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product
Table 99. Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
Table 100. Bharat Biotech Corporation Information
Table 101. Bharat Biotech Description and Business Overview
Table 102. Bharat Biotech Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Bharat Biotech Conjugate Vaccine Product
Table 104. Bharat Biotech Recent Developments/Updates
Table 105. Zhifei Biologic Corporation Information
Table 106. Zhifei Biologic Description and Business Overview
Table 107. Zhifei Biologic Conjugate Vaccine Sales (Million Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Zhifei Biologic Conjugate Vaccine Product
Table 109. Zhifei Biologic Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Conjugate Vaccine Distributors List
Table 113. Conjugate Vaccine Customers List
Table 114. Conjugate Vaccine Market Trends
Table 115. Conjugate Vaccine Market Drivers
Table 116. Conjugate Vaccine Market Challenges
Table 117. Conjugate Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Conjugate Vaccine
Figure 2. Global Conjugate Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Conjugate Vaccine Market Share by Type in 2023 & 2030
Figure 4. Hib Vaccine Product Picture
Figure 5. Meningococcal Vaccine Product Picture
Figure 6. Pneumococcal Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Conjugate Vaccine Market Value Comparison by End Users (2024-2030) & (US$ Million)
Figure 9. Global Conjugate Vaccine Market Share by End Users in 2023 & 2030
Figure 10. Children
Figure 11. Adult
Figure 12. Global Conjugate Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Conjugate Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Conjugate Vaccine Sales (2019-2030) & (Million Unit)
Figure 15. Global Conjugate Vaccine Average Price (USD/Unit) & (2019-2030)
Figure 16. Conjugate Vaccine Report Years Considered
Figure 17. Conjugate Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Conjugate Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Conjugate Vaccine Players: Market Share by Revenue in 2023
Figure 20. Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Conjugate Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Conjugate Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Conjugate Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Latin America Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Conjugate Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Conjugate Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Conjugate Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Conjugate Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Conjugate Vaccine by Type (2019-2030)
Figure 57. Global Conjugate Vaccine Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Conjugate Vaccine by End Users (2019-2030)
Figure 59. Global Revenue Market Share of Conjugate Vaccine by End Users (2019-2030)
Figure 60. Global Conjugate Vaccine Price (USD/Unit) by End Users (2019-2030)
Figure 61. Conjugate Vaccine Value Chain
Figure 62. Conjugate Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
